Clay Siegall: Blogging for a Good Cause

Throughout his career, Clay Siegall has won different hats but all with the primary goal of knowledge advancement. As a blogger, he tackles a wide variety of topics primarily with the aim of dispensing knowledge. In one of his blog posts, Siegall draws from his experience as a research scientist to tackle the problem of flawed scientific research results and how they impede drug development. He argues that research scientists are faced with numerous challenges including competition from peers and inadequate funding. Consequently, they have been forced to present flawed results obtained from hurried researches. In another post, Siegall highlights the effects of environmental pollution on the Great Barrier Reef including its biodiversity as the pollutants cause bleaching. These two non-related ideas are expertly covered and highlights Siegall’s grasp of knowledge and knowledge dispensation skills.

Academic and Career History and Lifetime Dedication

Clay Siegall holds a Doctor Philosophy degree in Genetics from George Washington University. He is also graduated from Maryland University a Bachelor of Science degree in Zoology. Upon graduation, Siegall worked as research scientist at National Cancer Institute among others. He is currently serving as the chief executive officer, chairman and president of Seattle Genetics, a company he cofounded in 1998. This is in addition to the board membership he holds for three separate companies and editorial duties for three journals.

Clay Siegall is an award-winning scientist with numerous patents to his name and author of several articles. His primary focus as a research scientist, professional in genetics, company executive and entrepreneur is finding cure for cancer. Currently, he is directing his efforts and those of Seattle Genetics towards developing innovative treatments and therapies for cancer. While his efforts have seen significant progress over the past few years with the development, approval by FDA and use of Adcetris in over sixty countries as a cancer therapy, Siegall believes with dedication, the company can develop over ten new drugs. To achieve this goal, Clay Siegall has actively sourced for capital to finance cancer drugs developments and cancer researches. His passion and dedication drive to find a cure for cancer using technology and innovation with the hope that one day cancer-related suffering will end.